ZIPRASIDONE HYDROCHLORIDE LOADED NANOSTRUCTURED LIPID CARRIERS (NLCS) FOR INTRANASAL DELIVERY: OPTIMIZATION AND IN VIVO STUDIES release_eiz2v2io2ffcdbjiiqfpgqni44

by PRAVEEN SIVADASU, GOWDA D. V., SIDDARAMAIAH H., HEMALATHA S.

Published in International Journal of Applied Pharmaceutics by Innovare Academic Sciences Pvt Ltd.

2019   p31-41

Abstract

Objective: The present study was an attempt to systemically deliver the most desirable schizophrenia drug, ziprasidone hydrochloride (ZRS) via the intranasal route using nanostructured lipid carrier (NLC) approach.
 Methods: The desired ZRS loaded NLCs were developed using central composite statistical design and the developed formulation was monitored for improving ZRS bioavailability and their brain targeting efficacy.
 Results: Pharmacokinetic studies revealed a 10 fold increase (ZRS blood-brain ratio) for NLCs administered through nasal route (in comparison to intravenous route). Similarly, the concentration of ZRS (in the brain) delivered via nasal route exhibits 4 fold increment at all-time points.
 Conclusion: Therefore, the obtained results suggest a potential nose to brain transport of loaded ZRS by effective bypassing of the Blood-Brain Barrier (BBB).
In application/xml+jats format

Archived Files and Locations

application/pdf  781.5 kB
file_ff2s7bberfevhnoj7k4jiepmlm
innovareacademics.in (web)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2019-11-07
Journal Metadata
Not in DOAJ
Not in Keepers Registry
ISSN-L:  0975-7058
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: a5d5127c-7fd1-4860-9bc4-cae16a10d71c
API URL: JSON